Erratum: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2024.1516456

IF: 4.7

2024-11-06

Frontiers in Oncology

Abstract:This article is an erratum on: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers

oncology

What problem does this paper attempt to address?

Erratum: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1532921

IF: 7.3

2024-12-12

Frontiers in Immunology

Abstract:This article is an erratum on: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

immunology
Erratum: New insights into the role of macrophages in cancer immunotherapy

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1427337

IF: 7.3

2024-05-17

Frontiers in Immunology

Abstract:This article is an erratum on: New insights into the role of macrophages in cancer immunotherapy

immunology
Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Zekun Li,Yongchun Pan,Shiyu Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qin Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Frontiers Production Office

DOI: https://doi.org/10.3389/fphar.2022.1092147

IF: 5.6

2022-11-22

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.973448.].

pharmacology & pharmacy
Erratum: Nodular cutaneous metastasis of the leg in advanced urothelial bladder carcinoma: a case report and systematic literature review

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2023.1286604

IF: 4.7

2023-09-29

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1216725.].

oncology
Erratum: Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer

DOI: https://doi.org/10.3233/BLC-219500

2021-03-19

Bladder Cancer

Abstract:[This corrects the article DOI: 10.3233/BLC-200013.].
Erratum to “Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis”

Chenglin Han,Zilong Wang,Shuxiao Chen,Lin Li,Yingkun Xu,Weiting Kang,Chunxiao Wei,Hongbin Ma,Muwen Wang,Xunbo Jin

DOI: https://doi.org/10.1155/2021/9857803

2021-12-14

Oxidative Medicine and Cellular Longevity

Abstract:[This corrects the article DOI: 10.1155/2021/8851763.].

cell biology
Erratum: Challenging Cases in Urothelial Cancer: Case 17

Mark S Soloway

DOI: https://doi.org/10.3233/BLC-219603

2021-03-19

Bladder Cancer

Abstract:[This corrects the article DOI: 10.3233/BLC-200007.].
Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics: Erratum

Ju Huang,Fengqiu Liu,Xiaoxia Han,Liang Zhang,Zhongqian Hu,Qinqin Jiang,Zhigang Wang,Haitao Ran,Dong Wang,Pan Li

DOI: https://doi.org/10.7150/thno.67168

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.29569.].

medicine, research & experimental
Erratum: Challenging Cases in Urothelial Cancer

Mark S Soloway

DOI: https://doi.org/10.3233/BLC-219601

2021-03-19

Bladder Cancer

Abstract:[This corrects the article DOI: 10.3233/BLC-200001.].
Erratum: Challenging Cases in Urothelial Cancer: Case 18

Mark S Soloway

DOI: https://doi.org/10.3233/BLC-219604

2021-03-19

Bladder Cancer

Abstract:[This corrects the article DOI: 10.3233/BLC-200009.].
Erratum to “Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy” [Bioact. Mater. 5 (2020) 542–552]

Ying Hao,YuWen Chen,XinLong He,Fan Yang,RuXia Han,ChengLi Yang,Wei Li,ZhiYong Qian

DOI: https://doi.org/10.1016/j.bioactmat.2020.05.005

IF: 18.9

2021-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2020.04.002.].

engineering, biomedical,materials science, biomaterials
Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Zekun Li,Yongchun Pan,Shizheng Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qiang Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Corrigendum: Nano-sonosensitized Sonodynamic Nanomedicine Augments Tumor-Selective Catalytic Tumor Eradication

Haixian Zhang,Yiming Li,Junying Liu,Chang Cai

DOI: https://doi.org/10.3389/fmats.2022.1103132

2022-01-01

Frontiers in Materials

Abstract:• please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.In the published article, there was a mistake in the Funding statement.
Dual Target Gene Therapy to EML4-ALK NSCLC by a Gold Nanoshell-Based System: Erratum

Siwen Li,Yuxi Liu,Yalan Rui,Liping Tang,Samuel Achilefu,Yueqing Gu

DOI: https://doi.org/10.7150/thno.43075

IF: 11.6

2020-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.24469.].
Erratum: Synthesis and photodynamic antimicrobial chemotherapy against multi-drug resistant Proteus mirabilis of ornithine-porphyrin conjugates in vitro and in vivo

Frontiers Production Office

DOI: https://doi.org/10.3389/fmicb.2023.1260368

IF: 5.2

2023-08-09

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2023.1196072.].

microbiology
Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases10 (2023) 1367–1401]

Uttpal Anand,Abhijit Dey,Arvind K Singh Chandel,Rupa Sanyal,Amarnath Mishra,Devendra Kumar Pandey,Valentina De Falco,Arun Upadhyay,Ramesh Kandimalla,Anupama Chaudhary,Jaspreet Kaur Dhanjal,Saikat Dewanjee,Jayalakshmi Vallamkondu,José M Pérez de la Lastra,Arvind K. Singh Chandel,José M. Pérez de la Lastra

DOI: https://doi.org/10.1016/j.gendis.2024.101211

IF: 7.376

2024-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.007.].

genetics & heredity,biochemistry & molecular biology
Erratum to: Fluorescent glycan nanoparticle-based FACS assays for the identification of genuine drug-resistant cancer cells with differentiation potential

Chenglong Wang,Wencai Guan,Rong Chen,Yael Levi-Kalisman,Yichun Xu,Liwen Zhang,Min Zhou,Guoxiong Xu,Hongjing Dou

DOI: https://doi.org/10.1007/s12274-021-3672-9

IF: 9.9

2021-06-24

Nano Research

Abstract:The article Fluorescent glycan nanoparticle-based FACS assays for the identification of genuine drug-resistant cancer cells with differentiation potential, written by Chenglong Wang et al., was erroneously originally published electronically on the publisher’s internet portal (currently SpringerLink) on 10 August 2020 with the Acknowledgements.

materials science, multidisciplinary,chemistry, physical,physics, applied,nanoscience & nanotechnology
Erratum: The role of the hepatitis B virus genome and its integration in the hepatocellular carcinoma

Frontiers Production Office

DOI: https://doi.org/10.3389/fmicb.2024.1502267

IF: 5.2

2024-10-08

Frontiers in Microbiology

Abstract:This article is an erratum on: The role of the hepatitis B virus genome and its integration in the hepatocellular carcinoma

microbiology
Erratum: Knowledge, attitudes, and current practices toward lung cancer palliative care management in China: a national survey

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2024.1516468

IF: 4.7

2024-11-06

Frontiers in Oncology

Abstract:This article is an erratum on: Knowledge, attitudes, and current practices toward lung cancer palliative care management in China: a national survey

oncology

Erratum: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers

Erratum: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

Erratum: New insights into the role of macrophages in cancer immunotherapy

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Erratum: Nodular cutaneous metastasis of the leg in advanced urothelial bladder carcinoma: a case report and systematic literature review

Erratum: Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer

Erratum to “Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis”

Erratum: Challenging Cases in Urothelial Cancer: Case 17

Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics: Erratum

Erratum: Challenging Cases in Urothelial Cancer

Erratum: Challenging Cases in Urothelial Cancer: Case 18

Erratum to “Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy” [Bioact. Mater. 5 (2020) 542–552]

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Corrigendum: Nano-sonosensitized Sonodynamic Nanomedicine Augments Tumor-Selective Catalytic Tumor Eradication

Dual Target Gene Therapy to EML4-ALK NSCLC by a Gold Nanoshell-Based System: Erratum

Erratum: Synthesis and photodynamic antimicrobial chemotherapy against multi-drug resistant Proteus mirabilis of ornithine-porphyrin conjugates in vitro and in vivo

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases10 (2023) 1367–1401]

Erratum to: Fluorescent glycan nanoparticle-based FACS assays for the identification of genuine drug-resistant cancer cells with differentiation potential

Erratum: The role of the hepatitis B virus genome and its integration in the hepatocellular carcinoma

Erratum: Knowledge, attitudes, and current practices toward lung cancer palliative care management in China: a national survey